MedTrace Logo

KYleena Satisfaction Study / Observational Study on User Satisfaction With the Levonorgestrel Intrauterine Delivery System Kyleena (LNG-IUS 12) in New Contraceptive Users and After Switching From Another Contraceptive Method

NCT03182140 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1134

Last updated 2021-03-29

No results posted yet for this study

Summary

The main goal of this non-interventional study (NIS) is to evaluate user satisfaction with Kyleena in a real-life setting and to identify factors which influence user satisfaction, taking into account previously used contraceptive methods and reasons for use of Kyleena.

Conditions

  • Contraception

Interventions

DRUG

Kyleena

Kyleena - intrauterine delivery system containing 19.5 mg LNG

Sponsors & Collaborators

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-07-06
Primary Completion
2019-12-19
Completion
2020-03-31

Countries

  • United States
  • Belgium
  • Canada
  • Germany
  • Mexico
  • Norway
  • Spain
  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03182140 on ClinicalTrials.gov